ProPhase Labs, Inc. (PRPH)
OTCMKTS
· Delayed Price · Currency is USD
0.150
-0.009 (-5.66%)
At close: Feb 27, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $775.05 thousand as of February 27, 2026. Its market cap has decreased by -90.86% in one year.
Market Cap
775.05K
Enterprise Value
8.05M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
Market Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 775.05K, a decrease of -84.63%. That is a compound annual growth rate of -6.02%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IDenta | 1.10M |
| NovelStem International | 421.93K |
| InVitro International | 1.82M |
| Centogene | 3.58M |
| Stella Diagnostics | 4.22M |
| Hypha Labs | 4.89M |
| Medical Imaging | 63.82K |
| Psychemedics | 10.10M |